Drug Registration
> PDF Forms > DEA Form 225
Instructions
DEA Form-225
APPLICATION FOR REGISTRATION
SECTION 1. APPLICANT IDENTIFICATION
Information must be typed or printed in the blocks provided
to help reduce data entry errors. A physical address is required in address
line 1; a post office box or continuation of address may be entered in
address line 2. Fee exempt applicant must list the address of the fee exempt
institution. The email address, point of contact, national provider id, and
date of birth are new data items that are in the process of OMB approval and
will soon be mandatory. They are requested in order to facilitate
communication o0r as required by inter-agency sharing requirements. Applicants
must enter a valid social security number (SSN), or a tax
identification number (TIN) if applying as a business entity.
Debt collection information is mandatory pursuant to the Debt
Collection Improvement Act of 1996.
SECTION 2. BUSINESS ACTIVITY
Indicate only one. Each type of business activity requires a
separate application. You are required to register as a
"manufacturer" if you manufacture a controlled substance or list 1
chemical and then distribute it.
SECTION 3A. DRUG SCHEDULES
Applicants should check all drug schedules to be handled.
However, applicants must still comply with state requirements; federal
registration does not overrule state restrictions. Check the order form box
only if you intend to purchase or to transfer schedule 1 and 2 controlled
substances. Order forms will be mailed to the registered address following
issuance of a Certificate of Registration.
3B. MANUFACTURERS ONLY
Mark the controlled substance schedule(s) handled in each
manufacturing stage listed.
3C. SCHEDULE CODES
Report all drug codes as required for your business
activity. Analytical labs are not required to list drug codes. Researchers
of schedule 2-5 need only report schedule 2 drug codes that will be
manufactured or imported as part of the research activity. Researchers of
schedule 1 must report drug codes. Distributors or reverse distributors must
list all schedule 1 and/or 2012 codes. Importers and
Exporters must check all schedule codes handled. Manufacturer must report
all schedule 1 and 2 drug codes, and check all codes that are manufactured
in bulk.
SECTION 4. STATE LICENSE(S)
Federal registration by DEA is based upon the applicant 's
compliance with applicable state and local laws. Applicants should contact
the local state licensing authority prior to completing this application. If
your state requires a license, provide that
number on this application.
SECTION 5. LIABILITY
Applicants must answer all four questions for the
application to be accepted for processing. If you answered "Yes"
to any question, provide an explanation in the space provided. If you
answered "Yes" to several of the question, then you must provide a
separate explanation describing the location, nature, and result of incident
for each "Yes" answer. If additional
space is required, you may attach a separate sheet of paper.
SECTION 6. EXEMPTION
Exemption from payment of application fee is limited to
federal, state or local government official or institution. The applicant's
superior or agency officer must certify exempt status. The signature,
authority title, and telephone number of the certifying official (other than
the applicant) must be provided. The address of the fee exempt institution
must appear in Section 1.
SECTION 7. METHOD OF PAYMENT
Indicate the desired method of payment. Make checks payable
to "Drug Enforcement Administration". Third-party checks or checks drawn on
foreign banks will not be accepted. FEES ARE NON-REFUNDABLE.
SECTION 8. APPLICANT'S SIGNATURE
Applicants MUST sign in this section or the application will
be returned. Card holder signature in section 7 does not fulfill this
requirement.
ATTACHMENTS:
Researchers must attach 3 copies of protocol, including
curriculum vitae, to conduct research with schedule I controlled substances.
For clinical investigations, researchers must first submit to FDA a
"Notice of Claimed Investigational Exemption for New Drug (IND)".
See DEA web site or CFR 1301.18 for further details.
NOTICE TO REGISTRANTS PAYING BY CHECK
Authorization to Convert Your Check:
Checks will be converted via electronic fund transfer (EFT).
EFT is the term used to refer to the process where we electronically
instruct your financial institution to transfer funds from your account to
our account, rather than processing your check. By sending a completed,
signed check, you authorize us to copy your check and to use the account
information from your check to make an EFT from your account for the same
amount on the check. If the EFT cannot be completed for technical reasons,
you authorize us to process the copy of your check.
Insufficient Funds:
The EFT from your account will usually occur within 24
hours, which is faster than a check is normally processed. Therefore, make
sure there are sufficient funds available in your checking account when you
send us your check. If the EFT cannot be completed because of insufficient
funds, we may try to make the transfer up to two times.
Transaction Information:
The EFT from your account will be on the account statement
you receive from your financial institution. However, the transfer may be in
a different place on your statement than the place where your checks
normally appear. For example, it may appear under "Other
Withdrawals" or "Other Transactions". You will not receive
your original check back from your financial institution. For security
reasons, we will destroy your original check, but we will keep a scanned
copy of the check for record-keeping purposes.
Your Rights:
You should contact your financial institution immediately if
you believe that the EFT reported on your account statement was not properly
authorized or is otherwise incorrect. Consumers have protections under
Federal law called the Electronic Fund Transfer Act for an unauthorized or
incorrect electronic fund transfer.
CONTACT INFORMATION
-
INTERNET: Information can be found on our
web site at www.deadiversion.usdoj.gov
TELEPHONE:
Headquarters Call Center: (800) 882-9539
WRITTEN INQUIRIES:
Drug Enforcement
Administration
Registration Section/ODR
P.O. Box 2639
Springfield, VA 22152-2639
SCHEDULE
AND DRUG CODES
Listed below are examples of drug codes for schedules I-V. Check
all drug
codes you handle as required.
If you bulk manufacture a substance, check the bulk column after the
applicable drug code.
For more
information, see our web site at www.deadiversion.usdoj.gov,
21 CFR 1308, or call 1-800-882--9539.
Analytical Lab |
not required to list drug codes |
Distributor |
must list all schedule I and/or 2012 drug codes |
Researcher w/Sched I |
must list schedule I drug codes |
Researcher w/Sched II – V |
must list sched ule
II drug codes to be manufactured or imported
as part of research |
Researcher Dog |
may handle schedules I - V ;
must list schedule I drug codes |
Manufacturer |
must list all schedule I & II drug codes |
Manufacturer BULK |
must list all schedule I & II drug codes |
Reverse Distributor |
must list all schedule I and/or 2012 drug codes |
Exporter or Importer |
must list all schedule I - V drug codes |
Canine Handler |
may handle schedule
1-5; must list schedule 1 drug codes. |
SCHEDULE I |
|
|
NARCOTIC & NON-NARCOTIC BASIC CLASSES |
CODE |
BULK?
|
3,4-Methylenedioxyamphetamine (MDA) |
7400 |
|
3,4-Methylenedioxymethamphetamine (MDMA) |
7405 |
|
4-Methyl - 2,5 - Dimethoxyamphetamine
(DOM, STP) |
7395 |
|
4-Methylaminorex (cis isomer)
(U4Euh, McN-422) |
1590 |
|
Alphacetylmethadol (except LAAM) |
9603 |
|
Bufotenine
(Mappine) |
7433 |
|
Marihuana
/
Cannabidiol |
7360 /7372 |
|
Diethyltryptamine (DET) ( |
7434 |
|
Difenoxin
1MG/25UG AtSO4 /DU (Motofen) |
9167 |
|
Dimethyltryptamine (DMT) |
7435 |
|
Etorphine (except
HCL) |
9056 |
|
Gamma
Hydroxybutyric Acid (GHB) |
2010 |
|
Heroin
(Diamorphine) |
9200 |
|
Ibogaine |
7260 |
|
Lysergic acid diethylamide (LSD) |
7315 |
|
Mescaline |
7381 |
|
Marihuana |
7360 |
|
Methaqualone (Quaalude) |
2565 |
|
Normorphine |
9313 |
|
Peyote |
7415 |
|
Psilocybin |
7437 |
|
Tetrahydrocannabinols (THC) |
7370 |
|
|
|
|
SCHEDULE II |
|
|
NARCOTIC & NON-NARCOTIC BASIC CLASSES |
CODE |
BULK? |
Amobarbital (Amytal, Tuinal) |
2125 |
|
Amphetamine (Dexedrine, Adderall) |
1100 |
|
Cocaine (Methyl benzoylecgonine) |
9041 |
|
Codeine (Morphine methyl ester) |
9050 |
|
Dextropropoxyphene (bulk) |
9273 |
|
Diphenoxylate |
9170 |
|
Diprenorphine (M50-50) |
9058 |
|
Ethylmorphine (Dionin) |
9190 |
|
Etorphine Hydrochloride (M-99) |
9059 |
|
Fentanyl (Duragesic) |
9801 |
|
Hydrocodone (Dihydrocodeinone) |
9193 |
|
Hydromorphone (Diaudid) |
9150 |
|
Levo-Alphacetylmethadol
(LAAM) |
9648 |
|
Levorphanol (Levo-Dromoran) |
9220 |
|
Meperidine (Demerol, Mepergan) |
9230 |
|
Methadone (Dolophine, Methadose) |
9250 |
|
Methamphetamine (Desoxyn) |
1105 |
|
Methylphenidate (Concerta, Ritalin) |
1724 |
|
Morphine (MS Contin, Roxanol) |
9300 |
|
Opium, powdered |
9639 |
|
Opium, raw |
9600 |
|
Oxycodone (Oxycontin, Percocet) |
9143 |
|
Oxymorphone (Numorphan) |
9652 |
|
Pentobarbital (bulk) (Nembutal) |
2270 |
|
Phencyclidine (PCP) |
7471 |
|
Secobarbital (Seconal, Tuinal) |
2315 |
|
Thebaine |
9333 |
|
|
|
|
SCHEDULE III |
|
|
NARCOTIC & NON-NARCOTIC BASIC CLASSES |
CODE |
BULK? |
Anabolic Steroids |
4000 |
|
Barbituric
acid derivative |
2100 |
|
Benzphetamine
(Didrex, Inapetyl) |
1228 |
|
Buprenorphine
(Buprenex, Temgesic) |
9064 |
|
Butabarbital |
2100/2175 |
|
Butalbital |
2100 /2165 |
|
Codeine c ombo
product (Empirin) |
9804 |
|
Dihydrocodeine
combo product (Compal) |
9807 |
|
Dronabinol
in sesame oil soft cap (Marinol) |
7369 |
|
Gamma-Hydroxybutyric Acid
preparations (Zyrem) |
2012 |
|
Hydrocodone
combo products (Lorcet, Vicodin) |
9806 |
|
Ketamine
(Ketaset, Ketalar) |
7285 |
|
Morphine
combo product |
9810 |
|
Nalorphine
(Nalline) |
9400 |
|
Opium
combo product (Paregoric) |
9809 |
|
Pentobarbital
suppository dosage
(FP3) |
227 0 |
|
Phendimetrazine
(Plegine, Bontril) |
1615 |
|
Thiopental |
2100/2329 |
|
|
|
|
SCHEDULE IV |
|
|
NARCOTIC & NON-NARCOTIC BASIC CLASSES |
CODE |
BULK? |
Alprazolam
(Xanax |
2882 |
|
Barbital
(Veronal, Plexonal) |
2145 |
|
Chloral Hydrate
(Noctec) |
2465 |
|
Chlordiazepoxide
(Librium) |
2744 |
|
Clonazepam
(Klonopin) |
2737 |
|
Clorazepate
(Tranxene) |
2768 |
|
Diazepam
(Valium) |
2765 |
|
Flurazepam
(Dalmane) |
2767 |
|
Lorazepam
(Ativan) |
2885 |
|
Meprobamate
(Milltown, Equanil) |
2820 |
|
Midazolam
(Versed) |
2884 |
|
Oxazepam
(Serax, Serenid-D) |
2835 |
|
Phenobarbital
(Fastin, Zantryl) |
2285 |
|
Phentermine |
1640 |
|
Temazepam
(Restoril) |
2925 |
|
Zolpidem
(Ambien, Stilnox) |
2783 |
|
|
|
|
SCHEDULE V |
|
|
NARCOTIC & NON-NARCOTIC BASIC CLASSES |
CODE
|
BULK?
|
Codeine preparations (Robitussin
A-C, Pediacof) |
9 050 |
|
Pyrovalerone
(Centroton, Thymergix |
1485 |
|
You may write in additional drug codes in this section.
Attach a separate sheet if additional drug codes must be
reported.
|